Professional Summary
Dr Rashda Abbasi is Principal Scientist at IBGE. Her professional interests include Cancer Research, Cancer Biomarkers, Targeted Cancer Therapy, Drug discovery, Nanomedicine, Synthetic lethal interactions, Toxicology and DNA damage.
Current Projects
- Cancer Diagnostic and Prognostic Biomarkers
- Gene Therapy
Completed Projects
- Multifunctional magnetoelectric nanoparticles loaded with anticancer drugs for cancer therapy
- Synergistic Nanocomposite-Herbal Strategy for Targeted Drug Delivery and Controlled Release
- Identification of Novel Leukemia Biomarker(s) for Clinical Decision Making, Disease Management & Design of Targeted Therapeutics
- Targeted Cancer Therapeutics
- Molecular/PCR-based diagnostic Kits
Diagnostic Services
- Under her supervision IBGE is offering a cost effective solution to detect the status of 85 cancer biomarkers.
- Beta-Thalassemia: HBB Mutation Screening and XMN1 status
- Immunofluorescence Based Testing for Renal and Skin Diseases
- She is also part of the team involved in the Primer Synthesis Facility & COVID Sampling Kits.
Grants & Funding
- NRPU, HEC (8.1 M)